Bukwang Pharm took over the Danish bio-venture ‘Contera’

Published: 2014-11-27 14:17:13

Updated: 2014-11-27 14:22:20

Bukwang Pharm (executive director Sang-hoon Kim) announced on the 25^ththat the company acquired the 100% shares of ‘Contera Pharma’, a bio-venture specializing in CNS and located in Copenhagen, Denmark, and completed the buyout procedure on the 24^th.

A person concerned in Bukwang Pharm stated “Based on the buyout of a Danish bio-venture ‘Contera’, Bukwang Pharm will strengthen research activit...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.